HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced ferrochelatase activity in fibroblasts from patients with porphyria variegata.

Abstract
Ferrochelatase deficiency has been shown in both porphyria variegata (PV) and erythropoietic protoporphyria (EPP). It has been suggested that in PV there is a decrease in the enzyme, whereas in EPP the enzyme is unstable. In the present study ferrochelatase activity was measured in skin fibroblasts from three patients with PV and three normal subjects. The enzymatic activity in the patients with PV (17.5 +/- 4.5 pmoles heme formed per 10(7) fibroblasts per hour) was 50% of that of the control group (31.0 +/- 3.2 pmoles heme formed per 10(7) fibroblasts per hour). This supports the contention that the enzyme is deficient in PV and that an inactive ferrochelatase is the primary deficiency in this type of porphyria.
AuthorsD J Viljoen, E Cayanis, D M Becker, S Kramer, B Dawson, R Bernstein
JournalAmerican journal of hematology (Am J Hematol) Vol. 6 Issue 3 Pg. 185-90 ( 1979) ISSN: 0361-8609 [Print] United States
PMID484541 (Publication Type: Journal Article)
Chemical References
  • Heme
  • Lyases
Topics
  • Fibroblasts (enzymology)
  • Heme (biosynthesis)
  • Humans
  • Lyases (deficiency)
  • Porphyrias (enzymology)
  • Protoporphyria, Erythropoietic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: